Harvard Bioscience, Inc. (HBIO)

0.5924 -0.03 (-4.45%) USD  |  NASDAQ  |  Jan 23, 16:00
0.60 +0.01 (+1.28%) After-Hours: 20:00
More

Harvard Bioscience Current Deferred Revenue (Quarterly)

Current Deferred Revenue (Quarterly) Chart

View Current Deferred Revenue (Quarterly) for HBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Quarterly) Benchmarks

View Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Bruker Corp. Upgrade
Azenta, Inc. Upgrade
Precipio, Inc. Upgrade
Bionano Genomics, Inc. Upgrade
Kestra Medical Technologies Ltd. --